Multimodal Imaging Market Size by Technology, Application, End-User, Region – Revenue Pool Analysis, Margin Structure Assessment, Capital Flow Trends, Competitive Benchmarking & Forecast to 2030
Overview
Multimodal Imaging Market size was valued at USD 4.34 Billion in 2023 and the total Multimodal Imaging Market revenue is expected to grow at a CAGR of 5.9% from 2024 to 2030, reaching nearly USD 6.48 Billion by 2030.
Multimodal Imaging Market Overview
The Multimodal Imaging Market involves the integration of two or more imaging modalities, such as MRI, CT, PET, and optical imaging, to capture comprehensive and complementary data for improved diagnosis, treatment planning, and research. This approach enhances the visualization of anatomical and functional details, leading to more accurate medical outcomes. Applications of multimodal imaging span across various medical fields, including oncology, neurology, cardiology, and research, where it is used for disease diagnosis, monitoring, and drug development. Market drivers include the growing prevalence of chronic diseases, advancements in imaging technology, increasing demand for non-invasive diagnostic tools, and rising investments in medical research and healthcare infrastructure. The integration of AI and machine learning to process and analyze multimodal data is further boosting market growth.
The report includes the analysis of impact of COVID-19 lock-down on the revenue of market leaders, followers, and disrupters. Since lock down was implemented differently in different regions and countries, impact of same is also different by regions and segments. The report has covered the current short term and long term impact on the market, same will help decision makers to prepare the outline for short term and long term strategies for companies by region.
To know about the Research Methodology:-Request Free Sample Report
Multimodal imaging has developed drastically in recent times owing to the rapid increase in the geriatric population and technological advancements in the development of imaging systems, this industry has witnessed a steady growth. Further, significant opportunities from emerging economies have helped to improve the adoption of multimodal imaging systems.
The report covers all the trends and technologies playing a major role in the growth of the multimodal imaging market during the forecast period. It highlights the drivers, restraints, and opportunities expected to influence market growth during 2024-2030.
Multimodal Imaging Market Dynamics
Rising Prevalence of Chronic Diseases
The increasing global burden of chronic diseases, particularly cancer, cardiovascular disorders, and neurodegenerative conditions, is a key driver for multimodal imaging. These diseases often require complex diagnostic and treatment approaches, where single imaging modalities may not provide enough detail. For example, combining PET (functional imaging) with CT or MRI (structural imaging) allows for more accurate tumor detection, staging, and treatment planning. This growing demand for enhanced diagnostic precision to support personalized medicine is accelerating the adoption of multimodal imaging technologies. Continuous innovations in imaging technologies, such as hybrid, have improved the quality, speed, and accuracy of imaging. Additionally, the integration of artificial intelligence and machine learning in imaging analysis has enhanced the ability to interpret complex multimodal datasets, enabling faster and more accurate diagnoses.
Complexity in Data Integration and Interpretation
Multimodal imaging generates large and complex datasets that can be difficult to integrate and interpret. Combining different types of data, such as functional and anatomical images, requires specialized expertise and sophisticated software for accurate analysis. The lack of standardized protocols and interoperability between imaging systems and data processing software can pose challenges, potentially leading to delays in diagnosis or treatment.
Expansion of Personalized Medicine and Growing Investment in Healthcare Infrastructure
The growth of personalized medicine offers significant opportunities for the multimodal imaging market. Personalized treatment plans, especially for cancer and cardiovascular diseases, rely on detailed diagnostic information that multimodal imaging can provide. As precision medicine advances, the demand for technologies that can offer both functional and structural insights will increase, expanding the market for multimodal imaging solutions. This aligns with the broader trend of developing targeted therapies and individualized treatment protocols based on detailed imaging data. Governments and private sectors are increasingly investing in healthcare infrastructure, particularly in emerging markets, creating opportunities for the expansion of multimodal imaging. Improved healthcare access, coupled with rising demand for advanced diagnostic tools, is driving the need for modernized hospitals and diagnostic centers equipped with state-of-the-art imaging technologies. Additionally, the incorporation of cloud-based systems for storing and sharing multimodal imaging data offers new business models and revenue streams for manufacturers.
Multimodal Imaging Market Segment Analysis
The diagnostic imaging centers segment held the dominant xx% market share in 2023. The diagnostic technique is also used in small animal imaging for drug discovery and development procedures. The technique helps in empathetic dynamic biological procedures, gene expression, enzyme and protein activity, progression, treatment of diseases, biodistribution, pharmacodynamics, or pharmacokinetics of drug molecules in model organisms. Such imaging data assist researchers in the study of the fundamental aspects of human-system function and dysfunction.
The PET/CT segment holds the largest xx% market share and is expected to dominate the market during the forecast period. The increasing demand for early and accurate cancer diagnosis, growing clinical evidence for the early detection of Alzheimer’s disease, increasing applications of PET/CT systems in cardiology, favorable reimbursement scenarios, and technological advancements in the field of PET/CT.
Multimodal Imaging Market Regional Analysis
In terms of region, the North America region holds the largest market share in 2023 this high market demand is driven by prevalent chronic diseases and an aging population, ample financial resources for advanced medical equipment investment, established regulatory frameworks ensuring safety and quality, active research collaboration, insurance coverage for advanced diagnostics, patient expectations for comprehensive care, and a competitive market environment fostering innovation.
Asia-Pacific will be the fastest-growing regional market owing to the accelerated economic growth of many countries in this region; growing government focus on the healthcare sector, and rising pharmaceutical research activities. Also, government initiatives towards the development of healthcare facilities and increasing health insurance penetration are the key factors propelling the growth of the Asia-Pacific multimodal imaging market.
The report covers the recent development in the global multimodal imaging market like in 2022, MR Solutions Ltd. launched pre-clinical CT scan models for serial multimodal imaging with MRI and CT scanners.
In 2023, Siemens Healthineers, a part of Siemens AG launched Biograph Vision PET/CT system with reduced crystal elements, proposing a higher spatial resolution that improves lesion detectability in cancer diagnosis.
The objective of the report is to present a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, industry-validated market data and projections with a suitable set of assumptions and methodology. The report also helps in understanding Global Multimodal Imaging Market dynamics, structure by identifying and analyzing the market segments and project the global market size. Further, the report also focuses on the competitive analysis of key players by product, price, financial position, product portfolio, growth strategies, and regional presence. The report also provides PEST analysis, PORTER’s analysis, and SWOT analysis to address the question of shareholders to prioritizing the efforts and investment in the near future to the emerging segment in Global Multimodal Imaging Market.
Multimodal Imaging Industry Ecosystem
Multimodal Imaging Market Scope: Inquire before buying
| Global Multimodal Imaging Market | |||
|---|---|---|---|
| Report Coverage | Details | ||
| Base Year: | 2023 | Forecast Period: | 2024-2030 |
| Historical Data: | 2018 to 2023 | Market Size in 2023: | USD 4.34 Bn |
| Forecast Period 2024 to 2030 CAGR: | 5.9% | Market Size in 2030: | USD 6.48 Bn |
| Segments Covered: | by Technology | PET/CT Systems SPECT/CT Systems PET/MR Systems OCT/Fundus Imaging Systems Other Multimodal Imaging Systems |
|
| by Application | Brain & Neurology Cardiology Oncology Ophthalmology Other Applications |
||
| by End-User | Hospitals Diagnostic Imaging Centers Other End Users |
||
Multimodal Imaging Market, by Region
North America (United States, Canada and Mexico)
Europe (UK, France, Germany, Italy, Spain, Sweden, Austria and Rest of Europe)
Asia Pacific (China, South Korea, Japan, India, Australia, Indonesia, Malaysia, Vietnam, Taiwan, Bangladesh, Pakistan and Rest of APAC)
Middle East and Africa (South Africa, GCC, Egypt, Nigeria and Rest of ME&A)
South America (Brazil, Argentina Rest of South America)
Multimodal Imaging Market, Key Players
1. Siemens AG
2. GE Healthcare
3. Koninklijke Philips N.V.
4. Bruker Corporation
5. Canon Inc.
6. Mediso Ltd.
7. MILabs B.V.
8. MR Solutions Ltd.
9. Northridge Tri-Modality Imaging, Inc.
10. PerkinElmer, Inc.
11. Shanghai United Imaging Healthcare Co., Ltd.
12. Heidelberg Engineering Inc.
13. Carl Zeiss AG.
14. Topcon Corporation
15. Spectrum Dynamics Medical.
16. Barco
17. FUJIFILM VisualSonics Inc
18. Surface Optics Corporation
Frequently Asked Questions:
1. Which region has the largest share in the Global Multimodal Imaging Market?
Ans: The North America region held the highest share in 2023.
2. What is the growth rate of the Global Multimodal Imaging Market?
Ans: The Global Multimodal Imaging Market is growing at a CAGR of 5.9% during the forecasting period 2023-2030.
3. What is the scope of the Global Multimodal Imaging market report?
Ans: The Global Multimodal Imaging Market report helps with the PESTEL, PORTER, Recommendations for Investors & Leaders, and market estimation of the forecast period.
4. Who are the key players in the Global Multimodal Imaging market?
Ans: The important key players in the Global Multimodal Imaging Market are – Siemens AG, GE Healthc, Koninklijke Philips N.V., Bruker Corporation, Canon Inc., Mediso Ltd., MILabs B.V., MR Solutions Ltd., Northridge Tri-Modality Imaging, Inc., PerkinElmer, Inc., Shanghai United Imaging Healthcare Co., Ltd., Appendix, Questionnaire, Available Customization, Heidelberg Engineering Inc., Carl Zeiss AG., Topcon Corporation, Spectrum Dynamics Medical., Siemens AG, Barco, FUJIFILM VisualSonics Inc, and Surface Optics Corporation
5. What is the study period of this market?
Ans: The Global Multimodal Imaging Market is studied from 2018 to 2030.